Literature DB >> 9271353

The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant.

D Siegel1, E M Bolton, J A Burr, D C Liebler, D Ross.   

Abstract

alpha-Tocopherolquinone (TQ), a product of alpha-tocopherol oxidation, can function as an antioxidant after reduction to alpha-tocopherolhydroquinone (TQH2). We examined the ability of human NAD(P)H:quinone oxidoreductase (NQO1) to catalyze the reduction of TQ to TQH2 in cell-free and cellular systems. In reactions with purified human NQO1, TQ was reduced to TQH2. Kinetic parameters for the reduction of TQ by NQO1 (Km = 370 microM; k(cat) = 5.6 x 10(3) min(-1); k(cat)/Km = 15 min(-1) x microM(-1)) indicate that NQO1 can efficiently reduce TQ to TQH2. A comparison of the rate of reduction of TQ and coenzyme Q10 by NQO1 showed that TQ is reduced more efficiently than coenzyme Q10. Experiments with either Chinese hamster ovary (CHO) cells stably transfected with human NQO1 or CHO cell sonicates demonstrated a correlation between NQO1 activity and TQ reduction to TQH2. CHO cells with elevated NQO1 generated and maintained higher levels of TQH2 after treatment with TQ relative to NQO1-deficient CHO cells. TQH2 generated from NQO1-mediated reduction of TQ prevented cumene hydroperoxide-induced lipid peroxidation in rat liver microsomes. In addition, cumene hydroperoxide-induced lipid peroxidation was inhibited more efficiently by TQ in CHO cell lines with elevated NQO1 activity. These data demonstrate that NQO1 can reduce TQ to TQH2 and that TQH2 can function as an efficient antioxidant. This work suggests that one of the physiological functions of NQO1 may be to regenerate antioxidant forms of alpha-tocopherol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271353     DOI: 10.1124/mol.52.2.300

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  59 in total

Review 1.  Benzene, NQO1, and genetic susceptibility to cancer.

Authors:  M T Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study.

Authors:  Silvia Bona; Andrea Janz Moreira; Graziella Ramos Rodrigues; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2014-11-05       Impact factor: 3.356

3.  Antioxidant reactions of alpha-tocopherolhydroquinone.

Authors:  D C Liebler; J A Burr
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

4.  Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: a potential adaptive mechanism for dopaminergic neuroprotection.

Authors:  Zhenquan Jia; Hong Zhu; Bhaba R Misra; Yunbo Li; Hara P Misra
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

5.  Activating PPARγ Increases NQO1 and γ-GCS Expression via Nrf2 in Thrombin-activated Microglia.

Authors:  Hang Hang; Li-Kun Wang; Si-Ying Ren; An-Jun Song; Guo-Feng Wu
Journal:  Curr Med Sci       Date:  2020-03-13

6.  Gamma-tocopheryl quinone stimulates apoptosis in drug-sensitive and multidrug-resistant cancer cells.

Authors:  Kenneth H Jones; Jennifer J Liu; Jennifer S Roehm; Jason J Eckel; Tobin T Eckel; Chad R Stickrath; Craig A Triola; Zongcheng Jiang; Gianna M Bartoli; David G Cornwell
Journal:  Lipids       Date:  2002-02       Impact factor: 1.880

7.  Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Authors:  Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2012-10-23       Impact factor: 3.641

Review 8.  Novel therapeutic approaches for Leber's hereditary optic neuropathy.

Authors:  Shilpa Iyer
Journal:  Discov Med       Date:  2013-03       Impact factor: 2.970

9.  A novel plasma membrane quinone reductase and NAD(P)H:quinone oxidoreductase 1 are upregulated by serum withdrawal in human promyelocytic HL-60 cells.

Authors:  Nathalie Forthoffer; Consuelo Gómez-Díaz; Rosario I Bello; María I Burón; Sergio F Martín; Juan C Rodríguez-Aguilera; Plácido Navas; José M Villalba
Journal:  J Bioenerg Biomembr       Date:  2002-06       Impact factor: 2.945

10.  Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells.

Authors:  Auemduan Prawan; Benjaporn Buranrat; Upa Kukongviriyapan; Banchob Sripa; Veerapol Kukongviriyapan
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.